Communiqués Novavax, Inc.

Actions

NVAX

US6700024010

Marché Fermé - Nasdaq Autres places de cotation 22:00:03 31/05/2024			Varia. 5j.	Varia. 1 janv.
15,04 ^USD	-1,38 %		-3,03 %	+213,12 %

24/05	Novavax attend la décision de la FDA pour savoir si son prochain vaccin COVID peut être proposé aux États-Unis	RE
24/05	NOVAVAX, INC. : B. Riley favorable sur le dossier	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	30/05	AQ
Novavax to Participate in 2024 Jefferies Global Healthcare Conference	30/05	PR
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	20/05	AQ
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	20/05	AQ
Novavax to Participate in BofA Securities 2024 Health Care Conference	13/05	PR
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	13/05	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	13/05	AQ
Q1 2024 Earnings presentation	10/05	PU
Novavax: Q1 Earnings Snapshot	10/05	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	10/05	PR
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024	07/05	PR
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting	06/05	AQ
Novavax : Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall	26/04	PU
Novavax : to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom	18/04	PU
Shah Capital nominates two highly qualified independent director candidates for Novavax	15/04	AQ
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024	01/04	PR
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference	29/02	PR
Novavax's Protein-based Non-mRNA COVID-19 Vaccine Available Now as Additional Dose for Individuals Aged 65 and Older Following U.S. CDC Advisory Committee Recommendation	29/02	AQ
Novavax: Q4 Earnings Snapshot	28/02	AQ
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	28/02	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Novavax bondit suite à l'accord de 1,2 milliard de dollars avec Sanofi pour un vaccin

Le 10 mai 2024 à 20:52